Baudax Bio, Inc.
Intranasal dexmedetomidine compositions and methods of use thereof

Last updated:

Abstract:

The present invention provides intranasal formulations comprising dexmedetomidine, or a pharmaceutically acceptable salt thereof, and uses thereof.

Status:
Grant
Type:

Utility

Filling date:

12 Sep 2017

Issue date:

16 Jun 2020